文献速递哮喘

哮喘与妊娠:叙述性综述

Asthma and Pregnancy: A Narrative Review.
PubMed 文献 · Chest · 2025-09-26

本综述评估当代哮喘管理原则在妊娠期的适用性,指出重度或控制不佳的哮喘增加先兆子痫、 gestational diabetes、胎儿生长受限、早产及新生儿并发症风险,生理变化不预期加重哮喘严重度,多数标准治疗包括生物制剂在妊娠和哺乳期安全。

要点

  • 重度或控制不佳的哮喘增加母婴不良结局风险。
  • 妊娠生理变化不预期加重哮喘,FEV1/FVC下降需进一步检查。
  • 多数标准治疗包括生物制剂在妊娠和哺乳期安全。

核心结论

  • 本综述更新了优化妊娠期哮喘管理的循证策略,支持主动管理、个体化治疗和持续纳入研究。

研究设计与样本

  • 叙述性综述,评估当代哮喘管理原则在妊娠期的适用性。

主要发现

  • 重度或控制不佳的哮喘增加先兆子痫、妊娠期糖尿病、胎儿生长受限、早产和新生儿并发症风险。
  • 母体不良结局还包括非计划入院、生活质量下降和心理共病。
  • 妊娠生理变化不预期加重哮喘严重度,FEV1/FVC比值下降应进一步检查。
  • 预测妊娠期恶化的因素包括哮喘严重度增加、控制欠佳和维持治疗不依从。

临床怎么用

  • 治疗依从性、管理共病和监测不良结局是哮喘管理原则。
  • 向患者保证药物安全性对促进依从性和改善母婴健康至关重要。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

TOPIC IMPORTANCE: Asthma, the most prevalent respiratory condition in pregnancy, affects up to 12% of pregnant women globally and is associated with adverse perinatal outcomes when poorly controlled. Modern asthma management emphasizes achieving clinical remission through personalized, trait-based approaches targeting modifiable risk factors. Insights into the mechanisms of airway inflammation have led to biomarker-directed therapy and the emergence of biologic agents for severe asthma. An evidence review was conducted to evaluate the applicability of these contemporary principles within the context of pregnancy. REVIEW FINDINGS: Severe or poorly controlled asthma increases the risk of preeclampsia, gestational diabetes, fetal growth restriction, preterm birth, and neonatal morbidity such as transient tachypnea of the newborn, intensive care admission, seizures, and hypoglycemia. Maternal adverse outcomes extend to unplanned hospital admissions, reduced quality of life, and psychological comorbidity. Physiological changes in pregnancy are not expected to worsen asthma severity, and any decline in FEV1 to FVC ratio should prompt further investigation. Factors that may predict deterioration in pregnancy include increased severity of asthma, suboptimal control, and nonadherence to maintenance therapy. The principles of asthma management include treatment adherence, managing comorbidities, and monitoring for adverse outcomes. Most standard treatments, including biologics if needed, are safe during pregnancy and lactation. Reassuring patients about medication safety is essential to promote adherence and to improve maternal and fetal health. SUMMARY: This review updates health care providers on evidence-based strategies for optimizing asthma care in pregnant women and supporting proactive management, personalized treatment, and ongoing inclusion in research.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Teelucksingh S, Davis A, Nelson-Piercy C, et al. Asthma and Pregnancy: A Narrative Review. Chest. 2025. PMID: 41015198. doi:10.1016/j.chest.2025.08.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。